Social media, celebrity endorsements, and sensationalised news coverage have created unrealistic expectations around GLP-1 weight loss treatments. Many patients arrive at consultations expecting rapid, dramatic weight loss with minimal effort or side effects. When reality does not match these expectations, adherence drops, dissatisfaction rises, and clinical outcomes suffer.
Practitioners play a critical role in bridging this expectation gap. Setting realistic, evidence-based expectations from the very first consultation is not just good clinical practice but also directly impacts treatment outcomes. Patients who understand what to expect are more likely to persist through the initial adjustment period and achieve meaningful, sustainable results. MJ Clinical Training equips practitioners with the communication skills and clinical knowledge to manage this conversation effectively.
Clinical trial data provides a solid foundation for expectation-setting conversations. The evidence shows that GLP-1 receptor agonists typically produce weight loss of ten to fifteen percent of total body weight over twelve to eighteen months when combined with lifestyle modifications. Some patients achieve more, some less, and individual variation is significant.
Weight loss is rarely linear. Patients commonly experience a rapid initial phase followed by a plateau, which can be demoralising if they have not been prepared for it. Practitioners should explain this pattern during the assessment phase, emphasising that plateaus are a normal physiological response rather than treatment failure. It is also essential to discuss the reality that weight management is a long-term process, not a short course of medication.
Effective expectation management starts with active listening. Before explaining what GLP-1 treatment can deliver, practitioners should explore what the patient hopes to achieve and why. Understanding their motivations, whether health-related, aesthetic, or functional, allows you to tailor your communication accordingly.
Using specific numbers rather than vague promises is more effective. Telling a patient they might expect to lose roughly one to two percent of their body weight per month gives them a concrete framework. Showing them what that looks like in kilograms personalises the information. Visual aids, progress charts, and examples from clinical trials can reinforce these messages without making individual guarantees.
Many patients will have seen dramatic before-and-after transformations on social media attributed to GLP-1 medications. Practitioners should acknowledge these images without dismissing the patient’s hopes. A balanced approach involves explaining that social media typically showcases exceptional results, that transformations often involve multiple interventions beyond medication alone, and that timelines shown online are frequently misleading.
Providing patients with reliable, evidence-based resources to take home reinforces the in-clinic conversation. MJ Clinical Training courses include patient information materials that practitioners can use or adapt for their own practice, ensuring consistent, accurate messaging between appointments.
Not every patient will respond to GLP-1 therapy as hoped. Practitioners need strategies for conversations where treatment is not producing expected results. This includes reassessing adherence, reviewing lifestyle factors, considering dose adjustments, and knowing when to discuss alternative or additional interventions.
Having discussed realistic outcomes from the outset makes these conversations significantly easier. When a patient was told from day one that ten to fifteen percent weight loss is a realistic target, a conversation about achieving eight percent feels very different from one where they expected to lose half their body weight. Honest, early communication protects both the therapeutic relationship and the patient’s mental health.
How do I handle patients who insist on unrealistic goals?
Document their stated goals, share the clinical evidence for realistic outcomes, and agree on measurable milestones together. If a patient’s expectations remain firmly unrealistic despite counselling, consider whether starting treatment is in their best interest, as disappointment can cause significant psychological harm.
Should I discuss weight regain during initial consultations?
Yes. Evidence shows that weight regain after stopping GLP-1 therapy is common. Discussing this early helps patients understand that long-term weight management may require ongoing treatment or robust lifestyle changes. Omitting this conversation sets patients up for disappointment later.
What training covers patient communication in weight management?
MJ Clinical Training courses include dedicated modules on patient communication, motivational interviewing, and expectation management specific to weight management prescribing. These practical skills are as important as the pharmacological knowledge.
Contact MJ Clinical Training today.
Patient Retention Summer Patient Disengagement in Weight Management Clinics: Keeping GLP-1 Patients on Track Through the Holidays Holidays, disrupted routines, and quieter clinics mean summer
Clinical Skills Weight Loss Plateaus in Summer: How Clinicians Can Support Patients Through Stalls and Motivation Dips Summer holidays, disrupted routines, and the natural physiology
Clinical Practice Managing GLP-1 Supply Disruption in Weight Management Clinics: A Summer Continuity Guide for Clinicians Intermittent supply of GLP-1 receptor agonists is now
